184 related articles for article (PubMed ID: 20840603)
1. Long-term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2-diabetic Goto-Kakizaki rats.
Peschke E; Schucht H; Mühlbauer E
J Pineal Res; 2010 Nov; 49(4):373-81. PubMed ID: 20840603
[TBL] [Abstract][Full Text] [Related]
2. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status.
Peschke E; Frese T; Chankiewitz E; Peschke D; Preiss U; Schneyer U; Spessert R; Mühlbauer E
J Pineal Res; 2006 Mar; 40(2):135-43. PubMed ID: 16441550
[TBL] [Abstract][Full Text] [Related]
3. Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes.
Peschke E; Wolgast S; Bazwinsky I; Pönicke K; Muhlbauer E
J Pineal Res; 2008 Nov; 45(4):439-48. PubMed ID: 18624957
[TBL] [Abstract][Full Text] [Related]
4. Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats.
Frese T; Bazwinsky I; Mühlbauer E; Peschke E
Horm Metab Res; 2007 Aug; 39(8):567-74. PubMed ID: 17712721
[TBL] [Abstract][Full Text] [Related]
5. Melatonin stimulates glucagon secretion in vitro and in vivo.
Bähr I; Mühlbauer E; Schucht H; Peschke E
J Pineal Res; 2011 Apr; 50(3):336-44. PubMed ID: 21244480
[TBL] [Abstract][Full Text] [Related]
6. Pineal melatonin synthesis is decreased in type 2 diabetic Goto-Kakizaki rats.
Frese T; Bach AG; Mühlbauer E; Pönicke K; Brömme HJ; Welp A; Peschke E
Life Sci; 2009 Sep; 85(13-14):526-33. PubMed ID: 19695268
[TBL] [Abstract][Full Text] [Related]
7. Influence of melatonin receptor signalling on parameters involved in blood glucose regulation.
Bazwinsky-Wutschke I; Bieseke L; Mühlbauer E; Peschke E
J Pineal Res; 2014 Jan; 56(1):82-96. PubMed ID: 24117965
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines are the key for explaining the biological relevance of insulin-melatonin antagonisms in type 1 and type 2 diabetes.
Peschke E; Hofmann K; Pönicke K; Wedekind D; Mühlbauer E
J Pineal Res; 2012 May; 52(4):389-96. PubMed ID: 21929683
[TBL] [Abstract][Full Text] [Related]
9. Adrenoceptor expression and diurnal rhythms of melatonin and its precursors in the pineal gland of type 2 diabetic goto-kakizaki rats.
Bach AG; Mühlbauer E; Peschke E
Endocrinology; 2010 Jun; 151(6):2483-93. PubMed ID: 20371702
[TBL] [Abstract][Full Text] [Related]
10. Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways.
Bähr I; Mühlbauer E; Albrecht E; Peschke E
J Pineal Res; 2012 Nov; 53(4):390-8. PubMed ID: 22672634
[TBL] [Abstract][Full Text] [Related]
11. Increased secretion and expression of amylin in spontaneously diabetic Goto-Kakizaki rats treated with rhGLP-1 (7-36).
Weng HB; Gu Q; Liu M; Cheng NN; Li D; Gao X
Acta Pharmacol Sin; 2008 May; 29(5):573-9. PubMed ID: 18430365
[TBL] [Abstract][Full Text] [Related]
12. Melatonin and type 2 diabetes - a possible link?
Peschke E; Stumpf I; Bazwinsky I; Litvak L; Dralle H; Mühlbauer E
J Pineal Res; 2007 Apr; 42(4):350-8. PubMed ID: 17439551
[TBL] [Abstract][Full Text] [Related]
13. Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging.
Sánchez-Hidalgo M; Guerrero Montávez JM; Carrascosa-Salmoral Mdel P; Naranjo Gutierrez Mdel C; Lardone PJ; de la Lastra Romero CA
J Pineal Res; 2009 Jan; 46(1):29-35. PubMed ID: 18513209
[TBL] [Abstract][Full Text] [Related]
14. Experimental and clinical aspects of melatonin and clock genes in diabetes.
Peschke E; Bähr I; Mühlbauer E
J Pineal Res; 2015 Aug; 59(1):1-23. PubMed ID: 25904189
[TBL] [Abstract][Full Text] [Related]
15. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.
Movassat J; Saulnier C; Serradas P; Portha B
Diabetologia; 1997 Aug; 40(8):916-25. PubMed ID: 9267986
[TBL] [Abstract][Full Text] [Related]
16. The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus).
Peschke E; Hofmann K; Bähr I; Streck S; Albrecht E; Wedekind D; Mühlbauer E
Diabetologia; 2011 Jul; 54(7):1831-40. PubMed ID: 21491159
[TBL] [Abstract][Full Text] [Related]
17. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
[TBL] [Abstract][Full Text] [Related]
18. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.
Murakawa Y; Zhang W; Pierson CR; Brismar T; Ostenson CG; Efendic S; Sima AA
Diabetes Metab Res Rev; 2002; 18(6):473-83. PubMed ID: 12469361
[TBL] [Abstract][Full Text] [Related]
19. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats.
Ríos-Lugo MJ; Cano P; Jiménez-Ortega V; Fernández-Mateos MP; Scacchi PA; Cardinali DP; Esquifino AI
J Pineal Res; 2010 Nov; 49(4):342-8. PubMed ID: 20663045
[TBL] [Abstract][Full Text] [Related]
20. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
